Q2 2012 13F Holders as of 30 Jun 2012
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.01 per share
-
Shares outstanding
-
1,148,777,709
-
Total 13F shares
-
1,456,652
-
Share change
-
-89,810
-
Total reported value
-
$57,458,313
-
Price per share
-
$39.44
-
Number of holders
-
11
-
Value change
-
-$3,539,366
-
Number of buys
-
6
-
Number of sells
-
4
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA) as of Q2 2012
As of 30 Jun 2012,
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,456,652 shares.
The largest 10 holders included
AGF Investments America Inc., Zurcher Kantonalbank (Zurich Cantonalbank), Dixon Mitchell Investment Counsel Inc., HUNTINGTON NATIONAL BANK, HUNTINGTON ASSET ADVISORS, INC., Northwest & Ethical Investments L.P., MUFG Americas Holdings Corp, Baskin Financial Services Inc., Dynamic Technology Lab Pte Ltd, and MCF Advisors LLC.
This page lists
11
institutional shareholders reporting positions in this security
for the Q2 2012 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.